2023 Hot Topic in Basic & Translational Science: Resistance to Io in Non-small cell lung cancer (NSCLC)

2023 Hot Topic in Basic & Translational Science: Resistance to Io in Non-small cell lung cancer (NSCLC) is organized by International Association for the Study of Lung Cancer (IASLC) and will be held from Nov 10 - 12, 2023 at Crowne Plaza Brussels Airport, Brussels, Belgium.

Description:
The clinical application of the immune checkpoint inhibitors (ICIs) that target PD-1, PD-L1, and CTLA-4 have shown significant and durable survival increases for a subset of patients with advanced NSCLC. However, the challenge in the usage of ICIs in lung cancer remains in understanding the biology of resistance, including predictive biomarkers beyond PD-L1 expression and the factors controlling either de novo or acquired resistance. Join us to discuss and present new and emerging data on immunoresistance in NSCLC! 

Additional details will be posted as soon as information is available.